Back
Altimmune Stock Predictions
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm
Buy
54
ALT
Altimmune
Last Price:
7.81
Seasonality Move:
0.83%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Altimmune Stock Forecast
- Over the next 52 weeks, Altimmune has on average historically risen by 25% based on the past 18 years of stock performance.
- Altimmune has risen higher in 7 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 38.89%
-
Is Altimmune Stock Undervalued?
The current Altimmune [ALT] share price is $7.43. The Score for ALT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal. - ALT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Altimmune Stock Go Up Next Year?
- Over the next 52 weeks, Altimmune has on average historically risen by 25% based on the past 18 years of stock performance.
Altimmune Stock Rating
Buy
54
Altimmune (ALT)
is a Buy
Is Altimmune overpriced?
- Altimmune has risen higher in 7 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 38.89%
Altimmune Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
altimmune.com
52-Week Data
52-Week High:
14.84
52-Week Low:
2.09
Prediction Charts
Market Cap:
528.06M
Price in USD:
7.43
Volume:
2.17M
Beta:
1.16
Technical Analysis
SMA50:
6.73
SMA100:
6.89
SMA200:
8.08
52-Wk Change:
174.17%
Stock Predictions
-
Is Altimmune stock public?
Yes, Altimmune is a publicly traded company. -
What is the Altimmune stock quote today?
The Altimmune stock price is 7.43 USD today. -
How to buy Altimmune stock online?
You can buy Altimmune shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Aug-29 | 6.54 | 6.61 | 6.89 | 6.49 |
| Aug-30 | 6.66 | 6.72 | 6.79 | 6.57 |
| Sep-3 | 6.67 | 6.38 | 6.76 | 6.27 |
| Sep-4 | 6.38 | 6.50 | 6.74 | 6.31 |
| Sep-5 | 6.50 | 6.40 | 6.51 | 6.28 |
| Sep-6 | 6.42 | 6.20 | 6.49 | 5.99 |
| Sep-9 | 6.22 | 6.38 | 6.52 | 6.20 |
| Sep-10 | 6.53 | 6.96 | 7.31 | 6.33 |
| Sep-11 | 6.92 | 7.17 | 7.21 | 6.74 |
| Sep-12 | 7.16 | 7.10 | 7.33 | 6.97 |
| Sep-13 | 7.14 | 7.88 | 8.25 | 7.14 |
| Sep-16 | 7.92 | 7.58 | 7.92 | 7.46 |
| Sep-17 | 7.67 | 7.57 | 7.94 | 7.46 |
| Sep-18 | 7.59 | 7.43 | 7.87 | 7.20 |
Altimmune Earnings
Altimmune Earnings Report: Per Share Altimmune Earnings Q1 Q2 Q3 and Q4 last year and next year.
Altimmune Forecast Revenue Growth
Altimmune Stock Analysis: Historical quarterly revenues per share for Altimmune and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.66 per share, and a decrease next year of $0.29 per share.
* Altimmune stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.